Spire Wealth Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5K | Buy |
17,847
+80
| +0.5% | +$78 | ﹤0.01% | 1557 |
|
|
2025
Q1 | $25.6K | Hold |
17,767
| – | – | ﹤0.01% | 1519 |
|
|
2024
Q4 | $39.1K | Hold |
17,767
| – | – | ﹤0.01% | 1375 |
|
|
2024
Q3 | $29.3K | Hold |
17,767
| – | – | ﹤0.01% | 1316 |
|
|
2024
Q2 | $39.4K | Hold |
17,767
| – | – | ﹤0.01% | 1202 |
|
|
2024
Q1 | $47.6K | Hold |
17,767
| – | – | ﹤0.01% | 1232 |
|
|
2023
Q4 | $35.9K | Buy |
17,767
+7,267
| +69% | +$14.7K | ﹤0.01% | 1316 |
|
|
2023
Q3 | $10.3K | Hold |
10,500
| – | – | ﹤0.01% | 1724 |
|
|
2023
Q2 | $14.6K | Hold |
10,500
| – | – | ﹤0.01% | 1702 |
|
|
2023
Q1 | $16.7K | Buy |
10,500
+386
| +4% | +$614 | ﹤0.01% | 1683 |
|
|
2022
Q4 | $63K | Hold |
10,114
| – | – | ﹤0.01% | 907 |
|
|
2022
Q3 | $68K | Hold |
10,114
| – | – | ﹤0.01% | 845 |
|
|
2022
Q2 | $64K | Hold |
10,114
| – | – | ﹤0.01% | 1194 |
|
|
2022
Q1 | $47K | Hold |
10,114
| – | – | ﹤0.01% | 1469 |
|
|
2021
Q4 | $51K | Buy |
+10,114
| New | +$51K | ﹤0.01% | 1715 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$2K | – | 2588 |
|
|
2021
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 2475 |
|
|
2021
Q1 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 2744 |
|